Whilst there is some evidence that M2 can have tumour inhibiting activity specifically in OS lung metastasis, it appears that more detailed evaluation of sub-populations such as CD68−/CD163+ at the single cell level may be a better biological endpoint if the study were to be repeated [37–40]. The gene discussed is CD68; the disease is neoplasm.